Century Therapeutics Reports Q2 2026 Financial Results

What Happened

• Century Therapeutics, Inc. filed a Form 8‑K on August 12, 2026 (Items 2.02 and 7.01) announcing its financial results for the quarter ended June 30, 2026.
• The company furnished a press release detailing those results as Exhibit 99.1 and an updated investor presentation as Exhibit 99.2. The presentation will be used by company representatives in investor meetings and roadshows.

Key Details

• Filing date: August 12, 2026.
• Reporting period: quarter ended June 30, 2026 (Q2 2026).
• Exhibits furnished: 99.1 — Press Release (financial results); 99.2 — Investor Presentation (updated deck).
• Disclosure type: Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD disclosure).

Why It Matters

• These documents contain the company’s most recent earnings and financial condition information; investors should review the press release and investor presentation for reported revenue, expenses, cash position, and any management commentary.
• The updated presentation may provide new or clarified guidance, milestones, or operational context that could affect investor outlook.
• The 8‑K does not report executive changes, mergers, or other material transactions beyond the earnings disclosure and presentation.